Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists
- 10 March 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (5) , 931-935
- https://doi.org/10.1016/s0960-894x(02)01029-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- (−)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF 2725]: A Dual PPAR Agonist with Potent Antihyperglycemic and Lipid Modulating ActivityJournal of Medicinal Chemistry, 2001
- Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ AgonistsJournal of Medicinal Chemistry, 2001
- FarglitazarDrugs of the Future, 2001
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Micronized Fenofibrate: A New Fibric Acid Hypolipidemic AgentAnnals of Pharmacotherapy, 1999
- Elevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart DiseaseCirculation, 1999
- Troglitazone. Is it all over?The Netherlands Journal of Medicine, 1999
- Troglitazone-Associated Hepatic FailureAnnals of Internal Medicine, 1999
- (3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agentsBioorganic & Medicinal Chemistry Letters, 1999
- Severe Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1999